XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1
FAIR VALUE MEASUREMENTS
3 Months Ended
Mar. 30, 2019
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS
Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates, yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets.
The following table details the fair value measurements of the Company’s financial assets:
 
 
 
Fair Value Measurement March 30, 2019 Using:
 
Total
 
Level 1
 
Level 2
 
Level 3
Cash and Cash Equivalents
$
16,583,525

 
$
16,583,525

 
$

 
$

U.S. Government Securities
11,170,700

 

 
11,170,700

 

Corporate Debt
9,118,217

 

 
9,118,217

 

GCS Holdings
336,384

 
336,384

 

 

Equity Investments
5,650,099

 

 

 
5,650,099

 
$
42,858,925

 
$
16,919,909

 
$
20,288,917

 
$
5,650,099

 
 
 
 
 
 
 
 
 
 
 
Fair Value Measurement December 29, 2018 Using:
 
Total
 
Level 1
 
Level 2
 
Level 3
Cash and Cash Equivalents
$
14,326,347

 
$
14,326,347

 
$

 
$

U.S. Government Securities
12,810,923

 

 
12,810,923

 

Corporate Debt
10,107,093

 

 
10,107,093

 

GCS Holdings
288,026

 
288,026

 

 

Equity Investments
5,565,499

 

 

 
5,565,499

 
$
43,097,888

 
$
14,614,373

 
$
22,918,016

 
$
5,565,499

Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows:
 
December 29, 2018
 
Net unrealized gains
 
Purchases, issuances and settlements
 
Transfers in and or out of Level 3
 
March 30, 2019
Equity Investments
$
5,565,499

 
$
84,600

 
$

 
$

 
$
5,650,099


The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature. If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy.
Marketable Debt Securities
The corporate debt consists of floating rate notes with a maturity that is over multiple years but has interest rates that are reset every three months based on the then-current three-month London Interbank Offering Rate ("three-month Libor"). The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model that incorporates the three-month Libor, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets.
Equity Investments
The Company acquired an equity interest in a company in the first quarter of 2018. The Company made a $1.0 million capital contribution during the three months ended March 31, 2018. The Company also contributed certain intellectual property. During the three months ended March 30, 2019, the Company recorded a $0.1 million unrealized gain on this equity investment due to a fluctuation in the foreign exchange rate. As of March 30, 2019, the Company owned an 11.0% interest in this investment and the fair value of this equity investment was approximately $3.7 million at March 30, 2019.
The Company owns an interest in an equity investment whose fair value was approximately $1.9 million at March 30, 2019. The Company adopted the measurement alternative for equity investments without readily determinable fair values (often referred to as cost method investments). As a result, these investments will be revalued upon occurrence of an observable price change for similar investments and for impairments. The Company did not have an observable price change for similar investments of its equity investments and recorded no impairments on its equity investments during the three months ended March 30, 2019.